Clarivate Plc filed a Form 8-K with the SEC on September 23, 2026, announcing that its wholly-owned subsidiary, Clarivate Science Holdings Corporation, had set the pricing terms for a previously announced cash tender offer for certain of its debt securities.

Key Highlights

  • Tender offer pricing announced: Clarivate Plc issued a press release on September 23, 2026, disclosing the pricing terms of the cash tender offer by Clarivate Science Holdings Corporation.
  • Subsidiary conducting offer: The tender offer is being conducted by Clarivate Science Holdings Corporation, described in the filing as a wholly-owned subsidiary of Clarivate Plc.
  • Debt securities targeted: The offer covers certain of Clarivate's debt securities, according to the filing.
  • Press release attached: A copy of the press release, dated September 23, 2026, is attached as Exhibit 99.1 and incorporated by reference into the filing.
  • Signed by General Counsel: The filing was signed by John Doulamis, Senior Vice President and General Counsel, on September 23, 2026.

Clarivate Science Holdings Corporation Sets Pricing for Cash Tender Offer on Debt Securities

According to the Form 8-K filed by Clarivate Plc (NYSE:CLVT) on September 23, 2026, the company's wholly-owned subsidiary, Clarivate Science Holdings Corporation, announced pricing terms for a cash tender offer targeting certain of Clarivate's outstanding debt securities. The filing notes that this tender offer had been previously announced, with the September 23, 2026 press release specifically addressing the pricing details.

The filing was made under Item 8.01 (Other Events) of Form 8-K. The full pricing terms are contained in the attached press release, Exhibit 99.1, which the filing states is incorporated by reference. The filing does not enumerate the specific debt securities involved, the offer price, or the aggregate principal amount within the body of the 8-K itself; those details are referenced as residing in the exhibit.

Clarivate Plc is incorporated in Jersey, Channel Islands, and maintains its principal offices at 70 St. Mary Axe, London, EC3A 8BE, United Kingdom. Its ordinary shares, which carry no par value, are listed on the New York Stock Exchange under the symbol CLVT. The filing was authorized and signed by John Doulamis, Senior Vice President and General Counsel.

What Was Disclosed

Clarivate Plc filed an 8-K on September 23, 2026, to report that its subsidiary Clarivate Science Holdings Corporation announced pricing terms for a previously disclosed cash tender offer for certain debt securities, with the full details provided in the attached press release, Exhibit 99.1.